Medical Device Stocks Surge 6% Following $2 Billion Buyback Announcement

Boston Scientific Corp. (BSX) shares closed at $55.91 on the New York Stock Exchange on the 18th, up 6.13% from the previous day, with trading volume of approximately 8.62 million shares. The company’s market capitalization climbed by about $5.4 billion (roughly ₩8.1 trillion) in a single day to reach around $83.1 billion (approximately ₩125 trillion).

On the same day, Boston Scientific announced it had entered into a $2 billion accelerated share repurchase agreement with J.P. Morgan, part of a broader $5 billion buyback program scheduled for completion by the end of June. Simultaneously, the company disclosed a $1.5 billion (about ₩2.3 trillion) strategic investment in spinal implant specialist MiRus, underscoring both its growth story and commitment to returning capital to shareholders.

Boston Scientific is a leading U.S. medical device manufacturer known for cardiovascular stents, cardiac rhythm-management systems, and peripheral vascular treatment devices. The company has expanded its revenue base by focusing on high-growth products such as the WATCHMAN left atrial appendage closure device.